U.S. Healthtech Stock News

Event driven interest around Playtika Holding stock Playtika Holding (PLTK) is drawing fresh attention after announcing a Bingo Blitz collaboration with Where’s Waldo? and a limited time coral reef protection event in Solitaire Grand Harvest, both focused on extending engagement in existing titles. See our latest analysis for Playtika Holding. These content partnerships come as Playtika Holding’s share price shows mixed momentum, with a 12.14% 7 day share price return and a 24.47% 90 day...

In recent days, Immunovant reported that its FcRn inhibitor Batoclimab achieved clinically meaningful improvements in a Phase IIb trial for chronic inflammatory demyelinating polyneuropathy (CIDP), supporting its potential use in this difficult autoimmune condition. This progress in CIDP adds another possible indication to Immunovant’s FcRn pipeline, deepening its footprint in autoimmune neurology alongside a crowded field of emerging competitors. Next, we’ll examine how Batoclimab’s...

Ameresco, Inc. recently announced a comprehensive, US$10 million-plus energy infrastructure upgrade for New York’s Mount Sinai School District, including full LED retrofits, rooftop solar arrays, high-efficiency transformers, and a fuel oil‑to‑natural gas conversion, scheduled to run from May 2026 through the end of 2027. By pairing long-term energy performance contracting with STEM programs that give students access to live energy data, the project links decarbonization, cost management,...

NCR Atleos recently announced that Global Credit Union has deployed its self-service ATMs at a new branch in Utqiagvik, Alaska, one of the most remote and extreme environments in the United States. This deployment underscores NCR Atleos’ ability to support reliable self-service banking in geographically isolated regions where infrastructure, weather, and logistics are especially challenging. We’ll now examine how NCR Atleos’ role in enabling remote self-service banking access in Utqiagvik...

Palladyne AI recently secured two U.S. Army contracts to research, develop, and operationally validate its SwarmOS and Gremlin-X systems with 4th Infantry Division warfighters, alongside integrating SwarmOS into the Army’s Next-Generation Command and Control ecosystem and showcasing capabilities at large-scale exercises like Northern Strike 26-2. By pairing these embodied AI and swarming validations with an exclusive U.S. production partnership for Israel Aerospace Industries’ HARPY, HAROP,...

If you are wondering whether Booking Holdings stock looks attractively priced after a mixed run, the current setup offers plenty of valuation questions worth unpacking. The share price recently closed at US$171.78, with the stock up 5.0% over the last week and 11.2% over the last month. It is still down 19.3% year to date and 18.1% over the past year, which can change how investors view both its potential and its risks. The latest move in Booking Holdings stock comes as investors react to...

FreeCast (CAST) stock has been back in focus after the company paired an expanded DIRECTV distribution deal with a new reseller agreement for Starlink Business connectivity, positioning its platform around bundled entertainment and broadband services. See our latest analysis for FreeCast. Those DIRECTV and Starlink Business announcements have coincided with extreme trading swings, with FreeCast’s share price return over the past week up more than 7x, the 30 day share price return above 260%,...

With the Federal Reserve holding rates at 3.5–3.75% and signaling that higher inflation could stick around longer than many expected, attention often turns to areas of the market that are tied to everyday essentials. Consumer staples stocks can sometimes offer a different risk and return profile to more cyclical areas when economic signals are mixed. This article looks at how that backdrop and the latest Fed commentary might affect a select group of large consumer staples companies, and...

AI is rapidly reshaping how work gets done, with top adopters reporting productivity growth of 163% and turning that into both higher wages and more hiring. That shift is raising the bar for human skills, especially in roles that rely on judgment, leadership, and creativity, and it is forcing companies to rethink how they train and develop talent. For investors, that puts Human Capital Development & Training Providers under the spotlight, as their services sit close to this skills...

Akso Health Group (AHG) recently reported a substantial jump in quarterly revenue alongside improved net profit. However, weak operating efficiency, financial health concerns, and limited disclosures are keeping investors focused on the durability of this shift. See our latest analysis for Akso Health Group. Despite the recent revenue headline, Akso Health Group’s share price has come under pressure, with a 30 day share price return down 17.79% and a 90 day share price return down 43.22%,...

Krystal Biotech (NasdaqGS:KRYS) reports strong revenue growth alongside progress in its rare disease pipeline. The company highlights ongoing clinical development for genetic therapies, including VYJUVEK for dystrophic epidermolysis bullosa. Recent updates focus on broader pipeline advancement in rare genetic conditions with high unmet medical need. Krystal Biotech enters the spotlight as investors track fresh updates on its revenue trajectory and expanding genetic therapy pipeline. The...

If you are wondering whether Ventas stock still offers value after its recent run, this article focuses squarely on what the current price might be implying about the company. Ventas shares last closed at US$81.60, with the stock down 2.7% over the past week and 7.6% over the past month, while still showing gains of 5.5% year to date and 33.7% over the past year, and a 102.1% return over three years and 66.7% over five years. Recent coverage of Ventas has centered on its position as a large...

With central banks hinting at tighter policy, oil headlines shifting inflation expectations, and credit trends diverging across regions, it can feel harder than ever to know where to focus. One anchor that still cuts through the noise is cash flow. Stocks that show promising cash flow potential yet trade below their SWS DCF fair value can offer a clear, numbers-based way to look for value. This article walks through 3 notable stocks from the Undervalued Stocks Based On Cash Flows screener and...

If you are wondering whether Commercial Metals stock still offers value after a strong run, this article walks through what the current price may be implying. The shares recently closed at US$72.36, with the price down 6.9% over the past week but up 4.4% over 30 days and 49.4% over the past year, which can change how investors think about both upside and risk. These moves sit against a backdrop of ongoing interest in metals and construction related companies. Investors often watch for...

Tariffs are back in the headlines, and that matters for small cap value stocks that live closer to the real economy than the mega caps most investors watch. Fresh proposals for new Section 301 tariffs, changes to metals duties, tighter customs enforcement, and a possible 25% tariff on Brazilian goods could shift costs and margins across supply chains. This article looks at three U.S. small cap value stocks that are closely exposed to these trade and enforcement moves, explaining why the same...

Credo Technology Group Holding (NasdaqGS:CRDO) has been named a 2026 USA TODAY Top Workplaces winner for the second consecutive year. The company also secured the 2026 San Francisco Bay Area Top Workplaces award for the third year in a row. These honors highlight Credo’s emphasis on an empowering, collaborative culture alongside its current position in the AI infrastructure market. For investors tracking Credo Technology Group Holding, the fresh Top Workplaces awards add another dimension...

If you are wondering whether Performance Food Group stock is starting to look expensive or still offers value, the current share price of US$103.62 makes valuation a key question. The stock is roughly flat over the past week, up 10.4% over the last month, 17.7% year to date and 21.9% over the past year. These moves put recent returns firmly on investors' radar. Over the past few months, Performance Food Group has stayed in focus as investors reassess consumer and food distribution companies...

La-Z-Boy (LZB) has just wrapped up FY 2026 with fourth quarter revenue of US$570.3 million, basic EPS of US$0.82 and net income of US$33.3 million, setting the tone for how the rest of the year’s numbers land with investors. The company has seen quarterly revenue shift between US$492.2 million and US$570.9 million over the last six reported periods, while basic EPS moved between US$0.36 and US$0.82 over the same window. This provides a clear view of how top line and EPS have tracked together...

JinkoSolar Holding (JKS) drew fresh investor attention after being named Overall Highest Achiever in the 2026 PV Module Index by RETC for the seventh year. This recognition underscores consistent product reliability and performance. See our latest analysis for JinkoSolar Holding. Recent price action around JinkoSolar Holding reflects mixed sentiment, with a 1-day share price return of 1.09% and 7-day gain of 4.63% set against a 30-day decline of 12.48% and year to date share price return down...

Rising tariff swings and fast supply chain changes are turning compliance and risk management from a back-office task into a front-line issue for investors. As companies rush to rework suppliers and shipping routes, the pressure around sanctions screening, export controls, and documentation is climbing. That is putting more attention on stocks tied to compliance and risk technology, where stronger tools can help businesses stay on the right side of regulators and protect margins. This article...

Recent bullish coverage from firms such as Canaccord Genuity, highlighting Twist Bioscience (TWST) silicon-based lab-on-a-chip platform and AI-enabled drug discovery efforts, has pushed Twist Bioscience stock firmly into focus for many investors. See our latest analysis for Twist Bioscience. That bullish research comes after a sharp move in the Twist Bioscience share price. The stock closed at US$82.87, with a 30 day share price return of 66.44% and a 1 year total shareholder return of...

The market in the United States has shown positive momentum, with a 2.0% increase over the last week and a notable 23% rise over the past year, while earnings are anticipated to grow by 19% annually in the coming years. In such an environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors looking to capitalize on undervalued assets amidst overall market growth.

The United States market has experienced a positive trajectory, with a 2.0% increase over the last week and a significant 23% rise in the past year, while earnings are projected to grow by 19% annually. In such an environment, stocks that not only demonstrate growth potential but also have high insider ownership can be particularly appealing as they suggest strong confidence from those closest to the company’s operations and future prospects.

The market has climbed 2.0% in the last 7 days and has seen a remarkable 23% increase over the past year, with earnings expected to grow by 19% annually. While penny stocks may seem like a term from another era, they still offer intriguing opportunities for investors seeking growth at accessible price points. By focusing on companies with strong financials and solid fundamentals, these stocks can present hidden value without many of the typical risks associated with this segment of the market.